These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11907106)

  • 41. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.
    Chapman TL; Heikeman AP; Bjorkman PJ
    Immunity; 1999 Nov; 11(5):603-13. PubMed ID: 10591185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
    Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
    J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog.
    Chapman TL; Bjorkman PJ
    J Virol; 1998 Jan; 72(1):460-6. PubMed ID: 9420246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
    Pizzato N; Garmy-Susini B; Le Bouteiller P; Lenfant F
    J Reprod Immunol; 2004 Jun; 62(1-2):3-15. PubMed ID: 15288176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis.
    Ben-Arieh SV; Zimerman B; Smorodinsky NI; Yaacubovicz M; Schechter C; Bacik I; Gibbs J; Bennink JR; Yewdell JW; Coligan JE; Firat H; Lemonnier F; Ehrlich R
    J Virol; 2001 Nov; 75(21):10557-62. PubMed ID: 11581431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection.
    Wagner CS; Riise GC; Bergström T; Kärre K; Carbone E; Berg L
    J Immunol; 2007 Mar; 178(6):3536-43. PubMed ID: 17339449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TRAM1 participates in human cytomegalovirus US2- and US11-mediated dislocation of an endoplasmic reticulum membrane glycoprotein.
    Oresic K; Ng CL; Tortorella D
    J Biol Chem; 2009 Feb; 284(9):5905-14. PubMed ID: 19121997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ubiquitination of MHC class I heavy chains is essential for dislocation by human cytomegalovirus-encoded US2 but not US11.
    Hassink GC; Barel MT; Van Voorden SB; Kikkert M; Wiertz EJ
    J Biol Chem; 2006 Oct; 281(40):30063-71. PubMed ID: 16877758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog.
    Leong CC; Chapman TL; Bjorkman PJ; Formankova D; Mocarski ES; Phillips JH; Lanier LL
    J Exp Med; 1998 May; 187(10):1681-7. PubMed ID: 9584146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells.
    Saverino D; Ghiotto F; Merlo A; Bruno S; Battini L; Occhino M; Maffei M; Tenca C; Pileri S; Baldi L; Fabbi M; Bachi A; De Santanna A; Grossi CE; Ciccone E
    J Immunol; 2004 May; 172(9):5629-37. PubMed ID: 15100307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol.
    Wiertz EJ; Jones TR; Sun L; Bogyo M; Geuze HJ; Ploegh HL
    Cell; 1996 Mar; 84(5):769-79. PubMed ID: 8625414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Herpes viral proteins blocking the transporter associated with antigen processing TAP--from genes to function and structure.
    Bauer D; Tampé R
    Curr Top Microbiol Immunol; 2002; 269():87-99. PubMed ID: 12224518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural and functional analysis of human cytomegalovirus US3 protein.
    Misaghi S; Sun ZY; Stern P; Gaudet R; Wagner G; Ploegh H
    J Virol; 2004 Jan; 78(1):413-23. PubMed ID: 14671122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human CD1d molecules are resistant to human cytomegalovirus US2- and US11-mediated degradation.
    Cho S; Jun Y
    Biochem Biophys Res Commun; 2011 Oct; 413(4):616-22. PubMed ID: 21925141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular proteins bind to sequence motifs in the R1 element between the HCMV immune evasion genes.
    Bullock GC; Thrower AR; Stinski MF
    Exp Mol Pathol; 2002 Jun; 72(3):196-206. PubMed ID: 12009783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human cytomegalovirus: host immune modulation by the viral US3 gene.
    Liu Z; Winkler M; Biegalke B
    Int J Biochem Cell Biol; 2009 Mar; 41(3):503-6. PubMed ID: 18992841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A structural determinant of human cytomegalovirus US2 dictates the down-regulation of class I major histocompatibility molecules.
    Oresic K; Noriega V; Andrews L; Tortorella D
    J Biol Chem; 2006 Jul; 281(28):19395-406. PubMed ID: 16687410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP.
    Hewitt EW; Gupta SS; Lehner PJ
    EMBO J; 2001 Feb; 20(3):387-96. PubMed ID: 11157746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.
    Cosman D; Fanger N; Borges L; Kubin M; Chin W; Peterson L; Hsu ML
    Immunity; 1997 Aug; 7(2):273-82. PubMed ID: 9285411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.
    Cerboni C; Achour A; Wärnmark A; Mousavi-Jazi M; Sandalova T; Hsu ML; Cosman D; Kärre K; Carbone E
    Eur J Immunol; 2006 Mar; 36(3):732-41. PubMed ID: 16479538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.